1. Home
  2. DNOW vs SUPN Comparison

DNOW vs SUPN Comparison

Compare DNOW & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNOW
  • SUPN
  • Stock Information
  • Founded
  • DNOW 1862
  • SUPN 2005
  • Country
  • DNOW United States
  • SUPN United States
  • Employees
  • DNOW N/A
  • SUPN N/A
  • Industry
  • DNOW Metal Fabrications
  • SUPN Biotechnology: Pharmaceutical Preparations
  • Sector
  • DNOW Industrials
  • SUPN Health Care
  • Exchange
  • DNOW Nasdaq
  • SUPN Nasdaq
  • Market Cap
  • DNOW 2.3B
  • SUPN 2.6B
  • IPO Year
  • DNOW N/A
  • SUPN 2012
  • Fundamental
  • Price
  • DNOW $13.95
  • SUPN $46.24
  • Analyst Decision
  • DNOW Strong Buy
  • SUPN Strong Buy
  • Analyst Count
  • DNOW 3
  • SUPN 4
  • Target Price
  • DNOW $17.33
  • SUPN $63.25
  • AVG Volume (30 Days)
  • DNOW 3.2M
  • SUPN 1.2M
  • Earning Date
  • DNOW 11-05-2025
  • SUPN 11-04-2025
  • Dividend Yield
  • DNOW N/A
  • SUPN N/A
  • EPS Growth
  • DNOW N/A
  • SUPN N/A
  • EPS
  • DNOW 0.87
  • SUPN N/A
  • Revenue
  • DNOW $2,432,000,000.00
  • SUPN $681,539,000.00
  • Revenue This Year
  • DNOW $5.86
  • SUPN $8.29
  • Revenue Next Year
  • DNOW $3.22
  • SUPN $22.72
  • P/E Ratio
  • DNOW $16.04
  • SUPN N/A
  • Revenue Growth
  • DNOW 3.18
  • SUPN 4.54
  • 52 Week Low
  • DNOW $12.01
  • SUPN $29.16
  • 52 Week High
  • DNOW $18.45
  • SUPN $57.65
  • Technical
  • Relative Strength Index (RSI)
  • DNOW 53.97
  • SUPN 45.50
  • Support Level
  • DNOW $12.01
  • SUPN $44.37
  • Resistance Level
  • DNOW $13.41
  • SUPN $46.47
  • Average True Range (ATR)
  • DNOW 0.66
  • SUPN 1.67
  • MACD
  • DNOW 0.13
  • SUPN -0.19
  • Stochastic Oscillator
  • DNOW 77.31
  • SUPN 62.09

About DNOW NOW Inc.

Dnow Inc is a company engaged in world-wide supplying of energy and industrial products and packaged, engineered process and production equipment with a legacy of over one sixty years. It offers a broad set of supply chain solutions combined with a suite of digital solutions branded as DigitalNOW that provide customers world-class technology for digital commerce, data and information management. Its locations provide products and solutions to exploration and production companies, midstream transmission and storage companies, refineries, chemical companies, utilities, mining, municipal water, manufacturers, engineering and construction companies. The Company has three reportable segments being United States, Canada and International.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: